Abata Therapeutics

Senior Clinical Trial Manager

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a scientific discipline, such as biology, pharmacy, or a related field, and have at least 7 years of experience in clinical trial management, with a minimum of 3 years specifically within dermatology or immunology. Demonstrated experience managing multiple clinical trials simultaneously is essential, along with a strong understanding of clinical trial regulations and guidelines.

Responsibilities

The Senior Clinical Trial Manager will lead and manage multiple clinical trials from initiation through completion, ensuring adherence to study timelines and budgets, collaborating with investigators, vendors, and cross-functional teams to ensure study execution and operational excellence. They will oversee the preparation and review of trial-related documentation, including protocols, informed consent forms, case report forms, and study reports, and drive cross functional study timelines related to trial setup and execution. Furthermore, the role involves fostering a collaborative team environment and ensuring seamless monitoring and data cleaning initiatives to meet study deliverables and timelines.

Skills

Clinical Trial Management
Regulatory Compliance
Study Planning
Operational Oversight
Documentation Review
Cross-functional Collaboration

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Key Metrics

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI